During the past decade, Urologikum Hamburg conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urologikum Hamburg" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Allergan" with 1 trials sponsored, "CureVac" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Novacea" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urologikum Hamburg" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Urologikum Hamburg" are "Prostate Cancer" (4 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Prostatic Neoplasms" (1 trials), "Urinary Bladder, Overactive" (1 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Urologikum Hamburg" in a lesser frequency.

Most popular intervention types in "Urologikum Hamburg" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abiraterone acetate (AA)" (1 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials) and "Bicalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologikum Hamburg" are 6 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Urologikum Hamburg". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Urologikum Hamburg, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Urologikum Hamburg, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".